SIS
SLDB icon

Sound Income Strategies’s Solid Biosciences SLDB Stock Holding History

Sound Income Strategies’s Portfolio SLDB Stock Details SLDB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.42K Buy
+1,005
New +$6.46K ﹤0.01% 1654

Other funds holding SLDB

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Sound Income Strategies's SLDB Position: Q1 2026 in Review

Sound Income Strategies opened a new position in Solid Biosciences (SLDB) in Q1 2026: 1,005 shares worth $7.42K. The stake represents ﹤0.01% of the portfolio and ranks #1654 among its holdings.

150 funds tracked by Wall St. Rank hold SLDB as of Q1 2026.

  • Sound Income Strategies held 1,005 shares of Solid Biosciences worth $7.42K as of Q1 2026.
  • Solid Biosciences was a new Sound Income Strategies position in Q1 2026.
  • Solid Biosciences made up ﹤0.01% of Sound Income Strategies's portfolio in Q1 2026, its #1654 holding.
  • 150 funds tracked by Wall St. Rank held Solid Biosciences as of Q1 2026.

Based on Sound Income Strategies's 13F filing for Q1 2026, filed 27 Apr 2026.